文献速递心血管外周血管CTPET

在体冠状动脉18F-氟化钠活性与冠状动脉斑块组织学易损性及生理环境的相关性

In Vivo Coronary 18F-Sodium Fluoride Activity: Correlations With Coronary Plaque Histological Vulnerability and Physiological Environment.
PubMed 文献 · JACC Cardiovasc Imaging · 2022-05-11

前瞻性研究纳入42例冠心病患者,评估在体冠状动脉18F-NaF PET/CT活性与离体组织学特征及生理环境的关系。高危斑块的18F-NaF活性显著高于低-中危斑块(中位数1.88 vs 1.12,P<0.001),鉴别高危斑块AUC为0.80。18F-NaF活性与组织学易损特征、CD68表达及炎症细胞因子表达相关,与成骨分化细胞因子无显著关联。

要点

  • 高危斑块的冠状动脉18F-NaF活性显著高于低-中危斑块(中位数1.88 vs 1.12,P<0.001)。
  • 冠状动脉18F-NaF活性鉴别高危斑块的AUC为0.80。
  • 18F-NaF活性与正性重构、低密度斑块、重塑指数等冠脉CTA不良斑块特征相关(均P<0.05)。

核心结论

  • 冠状动脉18F-NaF活性与组织学易损性、CD68表达及炎症细胞因子表达相关,但与成骨分化细胞因子表达无显著关联;18F-NaF PET/CT成像可能为检测高危冠状动脉斑块提供有力工具,并可能改善冠心病患者的风险分层。

研究设计与样本

  • 前瞻性研究,纳入42例冠心病患者,共获取55份冠状动脉内膜切除标本;患者接受冠状动脉CTA和18F-NaF PET/CT检查,对行冠状动脉旁路移植术并辅以冠状动脉内膜切除术患者的标本进行组织学易损性和免疫组化特征评估。

关键影像表现/征象

  • 高危标本的冠状动脉18F-NaF活性显著高于低-中危标本(中位数[第25-75百分位]:1.88[1.41-2.54] vs 1.12[0.91-1.54];P<0.001)。
  • 冠状动脉CTA不良斑块特征(正性重构、低密度斑块、重塑指数)与冠状动脉18F-NaF活性相关(均P<0.05)。
  • 组织学易损特征(大坏死核心、薄纤维帽、微钙化)与冠状动脉18F-NaF活性相关(均P<0.05)。

诊断标准与关键数值

  • 高危斑块与低-中危斑块依据标准病理分类定义。
  • 冠状动脉18F-NaF活性鉴别高危斑块的AUC为0.80。
  • CD68表达、肿瘤坏死因子-α表达及白细胞介素-1β表达与冠状动脉18F-NaF活性相关(均P<0.05)。
  • 冠状动脉18F-NaF活性与成骨分化细胞因子(骨桥蛋白、Runt相关转录因子2、骨钙素)无显著关联(均P>0.05)。

临床应用与阅片要点

  • 冠状动脉18F-NaF活性与组织学易损性、CD68表达及炎症细胞因子表达相关,作者认为18F-NaF PET/CT成像可能为检测高危冠状动脉斑块提供有力工具,并可能改善冠心病患者的风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: 18F-sodium fluoride (18F-NaF) positron emission tomography (PET)/computed tomography (CT) is a promising new approach for assessing microcalcification in vascular plaque.

OBJECTIVES: This prospective study aimed to evaluate the associations between in vivo coronary 18F-NaF PET/CT activity and ex vivo histological characteristics, to determine whether coronary 18F-NaF activity is a novel biomarker of plaque pathological vulnerability, and to explore the underlying physiological environment of 18F-NaF adsorption to vascular microcalcification.

METHODS: Patients with coronary artery disease (CAD) underwent coronary computed tomography angiography (CTA) and 18F-NaF PET/CT. Histological vulnerability and immunohistochemical characteristics were evaluated in coronary endarterectomy (CE) specimens from patients who underwent coronary artery bypass grafting with adjunctive CE. Correlations between in-vivo coronary 18F-NaF activity with coronary CTA adverse plaque features and with ex vivo CE specimen morphological features, CD68 expression, inflammatory cytokines expression (tumor necrosis factor-α, interleukin-1β), osteogenic differentiation cytokines expression (osteopontin, runt-related transcription factor 2, osteocalcin) were evaluated. High- and low- to medium-risk plaques were defined by standard pathological classification.

RESULTS: A total of 55 specimens were obtained from 42 CAD patients. Coronary 18F-NaF activity of high-risk specimens was significantly higher than low- to medium-risk specimens (median [25th-75th percentile]: 1.88 [1.41-2.54] vs 1.12 [0.91-1.54]; P < 0.001). Coronary 18F-NaF activity showed high discriminatory accuracy in identifying high-risk plaque (AUC: 0.80). Coronary CTA adverse plaque features (positive remodeling, low-attenuation plaque, remodeling index), histologically vulnerable features (large necrotic core, thin-fibro cap, microcalcification), CD68 expression, tumor necrosis factor-α expression, and interleukin-1β expression correlated with coronary 18F-NaF activity (all P < 0.05). No significant association between coronary 18F-NaF activity and osteogenic differentiation cytokines was found (all P > 0.05).

CONCLUSIONS: Coronary 18F-NaF activity was associated with histological vulnerability, CD68 expression, inflammatory cytokines expression, but not with osteogenic differentiation cytokines expression. 18F-NaF PET/CT imaging may provide a powerful tool for detecting high-risk coronary plaque and could improve the risk stratification of CAD patients.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Wen W, Gao M, Yun M, et al. In Vivo Coronary 18F-Sodium Fluoride Activity: Correlations With Coronary Plaque Histological Vulnerability and Physiological Environment. JACC Cardiovasc Imaging. 2022. PMID: 36648038. doi:10.1016/j.jcmg.2022.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。